申请人:BOY KENNETH M.
公开号:US20130030011A1
公开(公告)日:2013-01-31
The present disclosure provides a series of compounds of the formula (I)
which modulate β-amyloid peptide (β-AP) production and are useful in the treatment of Alzheimer's Disease and other conditions affected by β-amyloid peptide (β-AP) production.
本公开提供了一系列化合物,其化学式为 (I),可调节β-淀粉样肽(β-AP)的产生,并可用于治疗阿尔茨海默病和其他受β-淀粉样肽(β-AP)产生影响的疾病。